Progress in pig-to-non-human primate transplantation models (1998-2013): A comprehensive review of the literature

Xenotransplantation

Volumn 21, Issue 5, 2014, Pages 397-419

  Cooper, David K C ^a   Satyananda, Vikas ^a   Ekser, Burcin ^b,c   Van Der Windt, Dirk J ^a   Hara, Hidetaka ^a   Ezzelarab, Mohamed B ^a   Schuurman, Henk Jan ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d SchuBiomed Consultancy   (Netherlands)

Author keywords

islets; non human primate organs; pigs; xenotransplantation

Indexed keywords

15 DEOXYSPERGUALIN; ACETYLSALICYLIC ACID; AZATHIOPRINE; BELATACEPT; BETAMETHASONE; BREQUINAR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; FINGOLIMOD; GALACTOSE OLIGOSACCHARIDE; LOW MOLECULAR WEIGHT HEPARIN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISONE; RAPAMYCIN; RECOMBINANT ANTITHROMBIN III; TACROLIMUS; THYMOCYTE ANTIBODY; TRIAMCINOLONE;

ARTERY GRAFT; CARDIAC GRAFT REJECTION; CORNEA GRAFT REJECTION; CORNEA TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATOCYTE TRANSPLANTATION; IMMUNOADSORPTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; NERVE CELL; NONHUMAN; PANCREAS TRANSPLANTATION; PLASMAPHERESIS; PRIMATE MODEL; PRIORITY JOURNAL; REVIEW; SKIN TRANSPLANTATION; SPLENECTOMY; THROMBOCYTOPENIA; XENOTRANSPLANTATION; ANIMAL; ANIMAL MODEL; CELL TRANSPLANTATION; ORGAN TRANSPLANTATION; PIG; PRIMATE; PROCEDURES; XENOGRAFT;

ANIMALS; CELL TRANSPLANTATION; MODELS, ANIMAL; ORGAN TRANSPLANTATION; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84925448165     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12127     Document Type: Review

References (217)

1. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238-246.
2. Lexer G, Cooper DKC, Rose AG, et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 1986; 5: 411-418.
3. Lambrigts D, Sachs DH, Cooper DKC,. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998; 66: 547-561.
4. Hara H, Cooper DKC,. The immunology of corneal xenotransplantation: a review of the literature. Xenotransplantation 2010; 17: 338-349.
5. Hara H, Cooper DKC,. Xenotransplantation-the future of corneal transplantation? Cornea 2011; 30: 371-378.
6. Kim MK, Wee WR, Park CG, Kim SJ,. Xenocorneal transplantation. Curr Opin Organ Transplant 2011; 16: 231-236.
7. van der Windt DJ, Bottino R, Kumar G, et al. Clinical islet xenotransplantation: how close are we? Diabetes 2012; 61: 3046-3055.
8. Cooper DKC, Hara H, Yazer M,. Genetically engineered pigs as a source for clinical red blood cell transfusion. Clin Lab Med 2010; 30: 365-380.
9. Cozzi E, White DJ,. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964-966.
10. Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantation: the next medical revolution? Lancet 2012; 379: 672-683.
11. Cooper DKC, Koren E, Oriol R,. Genetically engineered pigs. Lancet 1993; 342: 682-683.
12. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255.
13. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101: 7335-7340.
14. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
15. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
16. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296-2304.
17. Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013; 20: 27-35.
18. Padler-Karavani V, Varki A,. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011; 18: 1-5.
19. Zhu X, Dor FJ, Cooper DKC,. Pig-to-non-human primate heart transplantation: immunologic progress over 20 years. J Heart Lung Transplant 2007; 26: 210-218.
20. Houser SL, Kuwaki K, Knosalla C, et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11: 416-425.
21. Cooper DKC,. A milestone in xenotransplantation research. Xenotransplantation 2013; 21: 13-15.
22. Mohiuddin MM, Corcoran PC, Singh AK, et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 2012; 12: 763-771.
23. Mohiuddin MM, Singh AK, Corcoran PC, et al. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model. Xenotransplantation 2013; 21: 35-45.
24. Mohiuddin MM, Singh AK, Corcoran PC, et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am J Transplant 2014; 14: 488-489.
25. Lin CC, Ezzelarab M, Shapiro R, et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010; 10: 1556-1568.
26. Baldan N, Rigotti P, Calabrese F, et al. Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events? Am J Transplant 2004; 4: 475-481.
27. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32-34.
28. Wu A, Esnaola NF, Yamada K, et al. Xenogeneic thymic transplantation in a pig-to-nonhuman primate model. Transplant Proc 1999; 31: 957.
29. Wu A, Yamada K, Awwad M, et al. Effects of xenogeneic thymic transplantation in baboons. Transplant Proc 2001; 33: 766.
30. Wu A, Yamada K, Awwad M, et al. Experience with porcine thymic transplantation in baboons. Transplant Proc 2000; 32: 1048.
31. Wu A, Yamada K, Neville DM, et al. Xenogeneic thymus transplantation in a pig-to-baboon model. Transplantation 2003; 75: 282-291.
32. Kim K, Schuetz C, Elias N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation 2012; 19: 256-264.
33. Valdes-Gonzalez RA, Dorantes LM, Garibay GN, et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005; 153: 419-427.
34. Sgroi A, Buhler LH, Morel P, Sykes M, Noel L,. International human xenotransplantation inventory. Transplantation 2010; 90: 597-603.
35. Elliott RB,. Towards xenotransplantation of pig islets in the clinic. Curr Opin Organ Transplant 2011; 16: 195-200.
36. Martin C, Plat M, Nerriere-Daguin V, et al. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res 2005; 14: 373-384.
37. Leveque X, Cozzi E, Naveilhan P, Neveu I,. Intracerebral xenotransplantation: recent findings and perspectives for local immunosuppression. Curr Opin Organ Transplant 2011; 16: 190-194.
38. Nagata H, Nishitai R, Shirota C, et al. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007; 132: 321-329.
39. Ezzelarab MB, Ekser B, Echeverri G, et al. Costimulation blockade in pig artery patch xenotransplantation-a simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation 2012; 19: 221-232.
40. Ierino FL, Gojo S, Banerjee PT, et al. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation 1999; 67: 1119-1128.
41. Weiner J, Yamada K, Ishikawa Y, et al. Prolonged survival of GalT-KO swine skin on baboons. Xenotransplantation 2010; 17: 147-152.
42. Denner J, Tonjes RR,. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev 2012; 25: 318-343.
43. Alwayn IP, Buhler L, Basker M, et al. Coagulation disorders associated with organ and cell xenotransplantation. Transplant Proc 2000; 32: 1099.
44. Ashton-Chess J, Roussel J-C, Manez R, et al. Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons. Xenotransplantation 2003; 10: 446-453.
45. Bauer A, Postrach J, Thormann M, et al. First experience with heterotopic thoracic pig to baboon cardiac xenotransplantation. Xenotransplantation 2010; 17: 243-249.
46. Bhatti FN, Schmoeckel M, Zaidi A, et al. Three month survival of hDAF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 3: 958.
47. Brenner P, Schmoeckel M, Reichenspurner H, et al. Technique of immunoapheresis in heterotopic and orthotopic xenotransplantation of pig hearts into cynomolgus and rhesus monkeys. Transplant Proc 2000; 32: 1987-1088.
48. Brenner P, Schmoeckel M, Wimmer C, et al. Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboons. Transplant Proc 2005; 31: 483-486.
49. Buhler L, Basker M, Alwayn IP, et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70: 1323-1331.
50. Byrne GW, Schirmer JM, Fass DN, et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005; 5: 1011-1020.
51. Byrne GW, Davies WR, Oi K, et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 2006; 82: 1787-1791.
52. Byrne GW, Stalboerger PG, Davila E, et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008; 15: 268-276.
53. Chan MC, Stalder M, Lam TT, et al. Use of echocardiography to assess function of hDAF-transgenic pig cardiac xenografts. Transplant Proc 2005; 37: 1923-1925.
54. Corcoran PC, Horvath KA, Singh AK, et al. Surgical and nonsurgical complications of a pig to baboon heterotopic heart transplantation model. Transplant Proc 2010; 42: 2149-2151.
55. Crespo FM, Centeno A, Lopez E, Juffe A, Manez R,. Abdominal laparoscopy in follow-up of heterotopic pig heart to baboon xenotransplantation. Transplant Proc 1999; 31: 2619.
56. Davila E, Byrne GW, LaBreche PT, et al. T-cell responses during pig to primate xenotransplantation. Xenotransplantation 2006; 13: 31-40.
57. Domenech N, Diaz T, Moscoso I, et al. Elicited non-anti-αGAL antibodies may cause acute humoral rejection of hDAF pig organs transplanted in baboons. Transplant Proc 2003; 35: 2049-2050.
58. Domenech N, Diaz T, Moscoso I, et al. Porcine endothelial cell activation in hDAF pig hearts transplanted in baboons with prolonged survival and lack of rejection. Transplant Proc 2003; 35: 2045-2046.
59. Dor FJ, Kuwaki K, Tseng YL,. Potential of aspirin to inhibit thrombotic microangiopathy in alpha1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons. Transplant Proc 2005; 37: 489-490.
60. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805-812.
61. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplanted from α1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008; 8: 2516-2526.
62. Horvath KA, Corcoran PC, Singh AK, et al. Left ventricular pressure measurement by telemetry is an effective means to evaluate transplanted heart function in experimental heterotopic cardiac xenotransplantation. Transplant Proc 2010; 42: 2152-2155.
63. Kim H, Chee HK, Yang J, et al. Outcomes of alpha 1,3-GT-knockout porcine heart transplants into a preclinical nonhuman primate model. Transplant Proc 2013; 45: 3085-3091.
64. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999; 67: 18-30.
65. Kuwaki K, Knosalla C, Dor FJMF, et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-CD154 monoclonal antibody-based regimen. Am J Transplant 2004; 4: 363-372.
66. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
67. Lam TT, Borie D, Masek M, et al. Graft thrombosis in hDa-transgenic pig hearts transplanted into rhesus monkeys. Xenotransplantation 2003; 10: 185-186.
68. Lam TT, Hausen B, Squiers E, et al. Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts. Transplant Proc 2002; 34: 1451-1452.
69. Lam TT, Hauser B, Boeke-Purkis K, et al. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha-Gal glycoconjugate GAS914. Xenotransplantation 2004; 11: 517-524.
70. Lam TT, Paniagua R, Shivaram G, et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004; 11: 531-535.
71. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745-1756.
72. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, et al. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667-1674.
73. Manez R, Crespo F, Gonzalez E, et al. Neutralization of anti-αGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons. Transplant Proc 2000; 32: 888-889.
74. Manez R, Domenech N, Centeno A, et al. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides. Xenotransplantation 2004; 11: 408-415.
75. Manez R, Lopez-Pelaez E, Centeno A, et al. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation. Transplantation 2004; 78: 930933.
76. McGregor CG, Teotia SS, Byrne GW, et al. Cardiac xenotransplantation: progress toward the clinic. Transplantation 2004; 78: 1569-1575.
77. McGregor CG, Davies WR, Oi K, et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005; 130: 844-851.
78. McGregor CGA, Ricci D, Miyagi N, et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal-knockout cardiac xenografts. Transplantation 2012; 93: 686-692.
79. Moscoso I, Hermida-Prieto M, Manez R, et al. lack of cross-species transmission of porcine endogenous retrovirus in pig-to-baboon xenotransplantation with sustained depletion of anti-alphagal antibodies. Transplantation 2005; 79: 777-782.
80. Ricci D, Tazelaar HD, Miyagi N,. The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation. J Heart Lung Transplant 2007; 26: 1025-1032.
81. Romano E, Neethling FA, Nilsson K, et al. Intravenous synthetic gal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation. Xenotransplantation 1999; 6: 36-42.
82. Schirmer JM, Fass DN, Byrne GW, et al. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation 2004; 11: 436-443.
83. Schuurman HJ, Pino-Chavez G, Phillips MJ, et al. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 2002; 73: 1146-1151.
84. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from α1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008; 172: 1471-1481.
85. Simon PM, Neethling FA, Taniguchi S, et al. Intravenous infusion of Galα1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998; 65: 346-353.
86. Stalder M, Tye T, Lam TT, et al. Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts. J Heart Lung Transplant 2005; 24: 215-221.
87. Tazelaar HD, Byrne GW, McGregor CG,. Comparison of Gal and non-Gal-mediated cardiac xenograft rejection. Transplantation 2011; 91: 968-975.
88. Teotia SS, Walker RC, Schirmer JM, et al. Prevention, detection, and management of early bacterial and fungal infections in a preclinical cardiac xenotransplantation model that achieves prolonged survival. Xenotransplantation 2005; 12: 127-133.
89. Tseng Y-L, Kuwaki K, Dor FJMF, et al. α 1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching six months. Transplantation 2005; 80: 1493-1500.
90. Waterworth PD, Dunning J, Tolan M, et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17: 1201-1207.
91. Weaver JG, McGregor CG, Tazelaar HD, Badley AD,. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. J Heart Lung Transplant 2005; 24: 841-847.
92. Wu G, Pfeiffer S, Schroder C, et al. Costimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft. Xenotransplantation 2005; 12: 197-208.
93. Wu G, Pfeiffer S, Schröder C, et al. Coagulation cascade activation triggers early failure of pig hearts expressing complement regulatory genes. Xenotransplantation 2007; 14: 34-47.
94. Zahorsky-Reeves JL, Kearns-Jonker MK, Lam TT, et al. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts. Xenotransplantation 2007; 14: 135-144.
95. Bauer A, Baschnegger H, Renz V, et al. Comparison of propofol and isoflurane anesthesia in orthotopic pig-to-baboon cardiac xenotransplantation. Xenotransplantation 2007; 14: 249-254.
96. Bauer A, Baschnegger H, Abicht JM, et al. hDAF porcine cardiac xenograft maintains cardiac output after orthotopic transplantation into baboon-a perioperative study. Xenotransplantation 2005; 12: 444-449.
97. Bauer A, Renz V, Baschnegger H, et al. Microcirculatory alterations after orthotopic pig-to-baboon heart transplant. Xenotransplantation 2011; 18: 232-238.
98. Brandl U, Michel S, Erhardt M, et al. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model. Xenotransplantation 2005; 12: 134-141.
99. Brandl U, Michel S, Erhardt M, et al. Transgenic animals in experimental xenotransplantation models: orthotopic heart transplantation in the pig to baboon model. Transplant Proc 2007; 39: 577-578.
100. Brenner P, Schmoeckel M, Wimmer C, et al. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons. Transplant Proc 2005; 37: 472-476.
101. Brenner P, Reichenspurner H, Schmoeckel M, et al. Prevention of hyperacute xenograft rejection in orthotopic xenotransplantation of pig hearts into baboons using immunoadsorption of antibodies and complement factors. Transpl Int 2000; 13 (Suppl 1): S508-S517.
102. Brenner P, Reichenspurner H, Schmoeckel M, et al. IG-therasorb immunoapheresis in orthotopic xenotransplantation of baboons with landrace pig hearts. Transplantation 2000; 69: 208-214.
103. Byrne GW, Du Z, Sun Z, Asmann YW, McGregor CG,. Changes in cardiac gene expression after pig-to-primate orthotopic xenotransplantation. Xenotransplantation 2011; 18: 14-27.
104. Schmoeckel M, Bhatti FN, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570-1577.
105. Vial CM, Ostlie DJ, Bhatti FN, et al. Life supporting function over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19: 224-229.
106. Xu H, Gundry SR, Hancock WW, et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig to baboon heart xenograft model. J Thorac Cardiovasc Surg 1998; 115: 1342-1349.
107. Ashton-Chess J, Muerette G, Karam G, et al. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide. Xenotransplantation 2004; 11: 112-122.
108. Ashton-Chess J, Rousell JC, Bernard P, et al. The effect of immunoglobulin immunadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons. Xenotransplantation 2003; 10: 552-561.
109. Barth RN, Yamamoto S, Lamattina JC, et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 2003; 75: 1615-1624.
110. Bhatti FNK, Zaidi A, Schmoeckel M, et al. Survival of life-supporting hDAF transgenic kidneys in primates is enhanced by splenectomy. Transplant Proc 1998; 30: 2467.
111. Bühler L, Yamada K, Kitamura H, et al. Pig kidney transplantation in baboons: anti-Gal (alpha) 1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001; 72: 1743-1752.
112. Cavicchioli L, De Zan G, Zappulli V, et al. Histopathological findings in the gastrointestinal tract of primate recipients of porcine renal xenografts following different immunosuppressive regimens. Xenotransplantation 2007; 14: 145-156.
113. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298.
114. Chen G, Sun H, Yang H, et al. The role of anti-non-gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006; 81: 273-283.
115. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig to primate renal xenotransplantation. Am J Transplant 2002; 2: 520-525.
116. Cowan PJ, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504-2515.
117. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of non-human primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15-21.
118. Cozzi E, Cadrobbi R, Baldan N, et al. Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. Xenotransplantation 2003; 10: 587-595.
119. Cozzi E, Simioni P, Boldrin M, et al. Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. Am J Transplant 2004; 4: 335-345.
120. Cozzi E, Vial C, Ostlie D, et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003; 10: 300-310.
121. Dean PG, Cohen AJ, Dalla Valle H, et al. The effect of anti-alphaGal antibody removal with immunoadsorption and splenectomy on CD46 transgenic kidney xenograft survival. Transplant Proc 2001; 33: 721-722.
122. Dehoux JP, De La Parra B, Latinne D, et al. Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft. Xenotransplantation 2002; 9: 338-349.
123. Dehoux JP, Hori S, Talpe S, et al. Specific depletion of preformed IgM natural antibodies by administration of anti-mu monoclonal antibody suppresses hyperacute rejection of pig to baboon renal xenografts. Transplantation 2000; 70: 935-946.
124. Diaz TM, Moscoso I, Centeno A, et al. Flow cytometry complement-mediated cytotoxicity assay detects baboon xenoantibodies directed to porcine epitopes undetected by hemolytic assay. Transpl Immunol 2004; 13: 313-317.
125. Garcia B, Sun HT, Yang HJ, Chen G, Zhong R,. Xenotransplantation of human decay accelerating factor transgenic porcine kidney to non-human primates: 4 years experience at a Canadian center. Transplant Proc 2004; 36: 1714-1716.
126. Ghanekar A, Lajoie G, Luo Y, et al. Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serum. Transplantation 2002; 74: 28-35.
127. Ghanekar A, Mendicino M, Liu H, et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 2004; 172: 5693-5701.
128. Gollackner B, Goh SK, Qawi I, et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004; 77: 1735-1741.
129. Gollackner B, Knosalla C, Houser S, et al. Pig kidney transplantation in baboons treated intravenously with a bovine serum albumin-Galα1-3Gal conjugate. Xenotransplantation 2003; 10: 606-614.
130. Gollackner B, Mueller NJ, Houser S, et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation 2003; 75: 1841-1847.
131. Griesemer AD, Hirakata A, Shimizu A, et al. Results of Gal-Knockout porcine thymokidney xenografts. Am J Transplant 2009; 9: 2669-2678.
132. Griesemer AD, Liang F, Hirataka A, et al. Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons. Xenotransplantation 2010; 17: 300-312.
133. Hecker JM, Lorenz R, Appiah R, et al. C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation 2002; 73: 688-694.
134. Ierino FL, Kozlowski T, Seigel JB, et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439-1450.
135. Key T, Schuurman HJ, Taylor CJ,. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens? Xenotransplantation 2004; 11: 452-456.
136. Knosalla C, Gollackner B, Bühler L, et al. Correlation of biochemical and hematological changes with graft failure following pig heart and kidney transplantation in baboons. Am J Transplant 2003; 3: 1510-1519.
137. Knosalla C, Yazawa K, Behdad A, et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant 2009; 9: 1006-1016.
138. Kobayashi T, Yokoyama I, Morozumi K, et al. Comparative study of the efficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis. Xenotransplantation 2000; 7: 101-108.
139. Lam TT, Hausen B, Hook L, et al. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Xenotransplantation 2005; 12: 20-29.
140. Le Bas-Bernardet S, Tillou X, Poirier N, et al. Xenotransplantation of galactosyl transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. Transplant Proc 2011; 43: 3426-3430.
141. Loss M, Arends H, Winkler M, et al. Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerism. Transpl Int 2001; 14: 31-37.
142. Loss M, Kunz R, Przemeck M, et al. Influence of cold ischemia time, pretransplant anti-porcine antibodies, and donor/recipient size matching on hyperacute graft rejection after discordant porcine to cynomolgus kidney transplantation. Transplantation 2000; 69: 1155-1159.
143. Loss M, Schmidtko J, Przemeck M, et al. A primate model for discordant pig to primate kidney xenotransplantation without hyperacute graft rejection. J Invest Surg 2001; 14: 21-29.
144. Loss M, Vangerow B, Schmidtko J, et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7: 186-196.
145. Loveland BE, Milland J, Kyriakou P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004; 11: 171-183.
146. Mcinnes EF, Jarrett RF, Langford G, et al. Posttransplant lymphoproliferative disorder associated with primate gamma-herpesvirus in cynomolgus monkeys used in pig-to-primate renal xenotransplantation and primate renal allotransplantation. Transplantation 2002; 73: 44-52.
147. Ménoret S, Plat M, Blancho G, et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. Transplantation 2004; 77: 1468-1471.
148. Meyer C, Wolf P, Romain N, et al. Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation. Transplantation 1999; 67: 38-45.
149. Nishimura H, Scalea J, Wang Z, et al. First experience with the use of recombinant CD3 immunotoxin as induction therapy in pig to primate xenotransplantation: the effect of T-cell depletion on outcome. Transplantation 2011; 92: 641-647.
150. Pintore L, Paltrinieri S, Vadori M, et al. Clinicopathological findings in non-human primate recipients of porcine renal xenografts: quantitative and qualitative evaluation of proteinuria. Xenotransplantation 2013; 20: 449-457.
151. Przemeck M, Vangerow B, Loss M, et al. Hemodynamic consequences of porcine kidney xenograft reperfusion in cynomolgus monkeys. Transplantation 2001; 71: 1512-1514.
152. Richards AC, Davies HF, Mclaughlin M, et al. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation. Transplantation 2002; 73: 881-889.
153. Schmoeckel M, Bhatti FN, Zaidi A, et al. Splenectomy improves survival of hDAF transgenic pig kidneys in primates. Transplant Proc 1999; 31: 961.
154. Shimizu A, Meehan SM, Kozlowski T, et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000; 80: 815-830.
155. Shimizu A, Yamada K, Robson SC, Sachs DH, Colvin RB,. Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol 2012; 23: 225-235.
156. Shimizu A, Yamada K, Yamamoto S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005; 16: 2745-3732.
157. Simioni P, Boldrin M, Gavasso S, et al. Effects of long-term administration of recombinant human protein C in xenografted primates. Transplantation 2011; 91: 161-168.
158. Spiezia L, Boldrin M, Radu C, et al. Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. Xenotransplantation 2013; 20: 89-99.
159. Sun H, Chen G, Liu W, et al. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection. Transplantation 2005; 80: 1331-1339.
160. Vangerow B, Hecker JM, Lorenz R, et al. C1-inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of hDAF transgenic porcine kidneys. Xenotransplantation 2001; 8: 266-272.
161. Xu Y, Lorf T, Sablinski T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65: 172-179.
162. Yazaki S, Iwamoto M, Onishi A, et al. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor. Xenotransplantation 2009; 16: 511-521.
163. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584-1590.
164. Zhong R, Luo Y, Yang H, et al. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003; 75: 10-19.
165. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 2010; 10: 273-285.
166. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989-998.
167. Ramírez P, Montoya MJ, Ríos A, et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc 2005; 37: 4103-4106.
168. Bush EL, Barbas AS, Holzknecht ZE, et al. Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants. Xenotransplantation 2011; 18: 6-13.
169. Cantu E, Balsara KR, Li B, et al. Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am J Transplant 2007; 7: 66-75.
170. Daggett CW, Yeatman M, Lodge AJ, et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 1998; 115: 19-27.
171. Gaca JG, Lesher A, Aksoy O, et al. The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation. Transplantation 2002; 74: 1596-1603.
172. Gaca JG, Appel JZ 3rd, Lukes JG, et al. Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction. Transplantation 2006; 81: 1686-1694.
173. Gonzalez-Stawinski GV, Daggett CW, Lau CL, et al. Non-anti-Gal alpha 1-3 Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg 2002; 194: 765-773.
174. Lau CL, Daggett WC, Yeatman MF, et al. The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thorac Cardiovasc Surg 2000; 120: 29-38.
175. Lau CL, Cantu E 3rd, Gonzalez-Stawinski GV, et al. The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation. Am J Transplant 2003; 3: 1065-1075.
176. Nguyen BN, Azimzadeh AM, Zhang T, et al. Life-supporting function of genetically modified swine lungs in baboons. J Thorac Cardiovasc Surg 2007; 133: 1354-1363.
177. Yeatman M, Daggett CW, Parker WW, et al. Complement-mediated pulmonary injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation 1998; 65: 1084-1093.
178. Buhler L, Deng S, O'Neil J, et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002; 9: 3-13.
179. Cantarovich D, Blancho G, Potiron N, et al. Rapid failure of pig islet transplantation in non human primates. Xenotransplantation 2002; 9: 25-35.
180. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
181. Cardona K, Milas Z, Strobert E, et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268.
182. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120-129.
183. Dufrane D, Goebbels RM, Saliez A, et al. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006; 81: 1345-1353.
184. Dufrane D, Goebbels RM, Gianello P,. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010; 90: 1054-1062.
185. Elliott RB, Escobar L, Calafiore R, et al. Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant Proc 2005; 37: 466-469.
186. Elliott RB, Escobar L, Tan PL, et al. Intraperitoneal alginate -encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 2005; 37: 3505-3508.
187. Garkavenko O, Dieckhoff B, Wynyard S, et al. Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol 2008; 80: 2046-2052.
188. Gianello P, Dufrane D,. Correction of diabetes mellitus type 1 on primate with encapsulated islet of pig pancreatic transplant. Bull Mem Acad R Med Belg 2007; 162: 439-449.
189. Graham ML, Schuurman H-J,. The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival. Xenotransplantation 2013; 20: 5-17.
190. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 2009; 106: 8659-8664.
191. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303.
192. Isaac JR, Skinner S, Elliot R, et al. Transplantation of neonatal porcine islets and sertoli cells into nonimmunosuppressed nonhuman primates. Transplant Proc 2005; 37: 487-488.
193. Igarashi Y, D'hoore W, Goebbels RM,. Beta-5 score to evaluate pig islet graft function in a primate pre-clinical model. Xenotransplantation 2010; 17: 449-459.
194. Jonker M, Rijkelijkhuizen JK, Haanstra KG, et al. T-cell-directed immunosuppression allows prolonged survival of xenogeneic pig islets in monkeys. Transplant Proc 2001; 33: 726.
195. Kim YH, Kim JS, Yoon IH, et al. Application of the multiplex cytokine analysis to monitor xenogeneic immune responses to the porcine islet graft in non-human primate. J Korean Med Sci 2013; 28: 1729-1733.
196. Kirchhof N, Shibata S, Wijkstrom M, et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004; 11: 396-407.
197. Komoda H, Miyagawa S, Omori T, et al. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase (GnT-III) in cynomolgus monkeys. Xenotransplantation 2005; 12: 209-216.
198. Lee JI, Shin JS, Jung WY, et al. Porcine islet adaptation to metabolic need of monkeys in pig-to-monkey intraportal islet xenotransplantation. Transplant Proc 2013; 45: 1866-1868.
199. Rijkelijkhuizen JK, Ossevoort M, Ringers J, et al. Xenografting of pig islets in monkeys does not result in hyperacute rejection. Transplant Proc 2000; 32: 1064.
200. Rijkelijkhuizen JK, Bouwman E, van der Burg MP, et al. Successful suppression of the early rejection of pig islets in monkeys. Cell Transplant 2000; 9: 909-912.
201. Rijkelijkhuizen JK, Haanstra KG, Wubben J, et al. T-cell-specific immunosuppression results in more than 53 days survival of porcine islets of langerhans in the monkey. Transplantation 2003; 76: 1359-1368.
202. Rogers SA, Chen F, Talcott MR, et al. Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques. Xenotransplantation 2007; 14: 591-602.
203. Rogers SA, Tripathi P, Mohanakumar T, et al. Engraftment of cells from porcine islets of Langerhans following transplantation of pig pancreatic primordia in non-immunosuppressed diabetic rhesus macaques. Organogenesis 2011; 7: 154-162.
204. Rood PP, Bottino R, Balamurugan AN, et al. Reduction of early graft loss after intraportal porcine islet transplant in monkeys. Transplantation 2007; 83: 202-210.
205. Söderlund J, Wennberg L, Castaños-Velez E, et al. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999; 67: 784-791.
206. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957.
207. Thompson P, Badell IR, Lowe M, et al. Islet xenotransplantation using Gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602.
208. Thompson P, Badell IR, Lowe M, et al. Alternative immunomodulatory strategies for xenotransplantation: CD40-CD154Pathway sparing regimens promote xenograft survival. Am J Transplant 2012; 12: 1765-1775.
209. van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
210. Vériter S, Gianello P, Igarashi Y, et al. Improvement of subcutaneous bioartificial pancreas vascularization and function by co-encapsulation of pig islets and mesenchymal stem cells in primates. Cell Transplant 2013; doi: 10.3727/096368913X663550 [Epub ahead of print].
211. Amano S, Shimomura N, Kaji Y, et al. Antigenicity of porcine cornea as xenograft. Curr Eye Res 2003; 26: 313-318.
212. Choi HJ, Kim MK, Lee HJ, et al. Efficacy of pig to rhesus lamellar corneal xenotransplantation. Invest Ophthalmol Vis Sci 2011; 52: 6643-6650.
213. Choi HJ, Lee JJ, Kim MK, et al. Cross-reactivity between decellularized porcine corneal lamellae for corneal xenobridging and subsequent corneal allotransplantation. Xenotransplantation 2014; 21: 115-123.
214. Jie Y, Liu L, Pan Z, Wang L,. Survival of pig-to-rhesus corneal xenografts prolonged by prior donor bone marrow transplantation. Mol Med Rep 2013; 7: 869-874.
215. Li A, Pan Z, Jie Y, et al. Comparison of immunogenicity and porcine to rhesus lamellar corneal xenografts survival between fresh preserved and dehydrated porcine corneas. Xenotransplantation 2011; 18: 46-55.
216. Pan Z, Sun C, Jie Y, et al. WZS-pig is a potential donor alternative in corneal xenotransplantation. Xenotransplantation 2007; 14: 603-611.
217. Luo Y, Kosanke S, Mieles L, et al. Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate. Xenotransplantation 1998; 5: 197-206.